Victor Moreno
@VicMorenoGarcia
Medical Oncology. START Madrid-FJD. Hospital Universitario Fundación Jiménez Díaz - Early Phase Clinical Trials Unit
30-09-2013 16:31:51
453 Tweets
902 Followers
288 Following
Happy to share the final results of the phase 1 study of BET inhibitor Trotabresib published in Nature Communications. Now focused on GBM Fundación Jiménez Díaz nature.com/articles/s4146…